- The NIH awarded Vibrent Health $39 million in a deal to boost its ‘All of Us’ research initiative’s tech platform.
- More DTC genetic testing vendors will likely roll out hospital-facing tools in response to growing interest.
- Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here.
The US National Institutes of Health (NIH) awarded digital health company Vibrent Health with $39 million to construct the tech backbone—which includes a platform for wide-scale data collection and digital tools for participant recruitment and engagement—for its ‘All of Us’ precision medicine research initiative for the next five years.
For context, the NIH launched the All of Us research initiative in 2018 with the aim of enrolling 1 million US